Registration Opening Soon for BOS Events 2025!

Dates for BOS Events 2025 are confirmed as 11th and 12th June for BOS Basel 2025 and 25th and 26th November for BOS Manchester 2025. Please find further details outlining provisional floor plans and pricing options at the event links provided. Note that we plan to open for registrations on Monday 4th November at 09.00 GMT.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Follow us on LinkedIn to see our latest announcements


Featured Company (BOS Basel 2024)

Logo for LAURUS SYNTHESIS PRIVATE LIMITED
LAURUS SYNTHESIS PRIVATE LIMITED
• Providing end-to-end CDMO Services to Pharma (Human and Animal Health) and Crop Protection Industries
• Drug Substance Development in our R&D facility with more than 1000 scientists. Supported by latest lab scale process equipment and analytical instruments
• Drug Product Development integrating...
View profile

Featured Speaker (BOS Basel 2024)

photo of Dr Dr Grace Lee

Navigating the Complexity of Cell and Gene Therapy Development and Outsourcing

Dr Grace Lee, Founder and Consultant, Elevalue Consulting LLC

ABSTRACT: The cell and Gene Therapies (CGT) landscape is rapidly changing and is characterized by a significant upsurge in clinical trials and outsourcing endeavors.
External partnerships play a pivotal role within this framework, particularly for small—to mid-sized biotech companies with limited experience in Good Manufacturing Practice (GMP) compliance for new modalities. In this presentation, Dr. Lee will provide insight into the complexity of CGT development and the critical components to consider in outsourcing partnerships with case studies.

Click here to Read More